{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:34:31Z","timestamp":1791340471311,"version":"4.3.1"},"reference-count":33,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,8,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Anaplastic large-cell lymphomas (ALCLs) are a group of clinically and biologically heterogeneous diseases including the ALK+ and ALK\u2212 systemic forms. Whereas ALK+ ALCLs are molecularly characterized and can be readily diagnosed, specific immunophenotypic or genetic features to define ALK\u2212 ALCL are missing, and their distinction from other T-cell non-Hodgkin lymphomas (T-NHLs) remains controversial. In the present study, we undertook a transcriptional profiling meta-analysis of 309 cases, including ALCL and other primary T-NHL samples. Pathway discovery and prediction analyses defined a minimum set of genes capable of recognizing ALK\u2212 ALCL. Application of quantitative RT-PCR in independent datasets from cryopreserved and formalin-fixed paraffin-embedded samples validated a 3-gene model (TNFRSF8, BATF3, and TMOD1) able to successfully separate ALK\u2212 ALCL from peripheral T-cell lymphoma not otherwise specified, with overall accuracy near 97%. In conclusion, our data justify the possibility of translating quantitative RT-PCR protocols to routine clinical settings as a new approach to objectively dissect T-NHL and to select more appropriate therapeutic protocols.<\/jats:p>","DOI":"10.1182\/blood-2012-01-405555","type":"journal-article","created":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T00:19:25Z","timestamp":1340929165000},"page":"1274-1281","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":102,"title":["Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma"],"prefix":"10.1182","volume":"120","author":[{"given":"Luca","family":"Agnelli","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milano; Hematology 1, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Mereu","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences; Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Pellegrino","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences; Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Limongi","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences; Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Kwee","sequence":"additional","affiliation":[{"name":"Lymphoma and Genomics Research Program, Institute of Oncology Research, Bellinzona, Switzerland;"},{"name":"Dalle Molle Institute for Artificial Intelligence, Manno, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Bergaggio","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences; Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[{"name":"Pathology and Lymphoid Malignancies Units, San Raffaele Scientific Institute, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Zam\u00f2","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Verona, Verona, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javeed","family":"Iqbal","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Paolo","family":"Piccaluga","sequence":"additional","affiliation":[{"name":"Institute of Hematology and Medical Oncology, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Neri","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milano; Hematology 1, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing C.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pileri","sequence":"additional","affiliation":[{"name":"Institute of Hematology and Medical Oncology, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bertoni","sequence":"additional","affiliation":[{"name":"Lymphoma and Genomics Research Program, Institute of Oncology Research, Bellinzona, Switzerland;"},{"name":"Lymphoma Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Inghirami","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences; Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy;"},{"name":"Department of Pathology and New York University Cancer Center, New York University School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Piva","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences; Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy;"},{"name":"Department of Pathology and New York University Cancer Center, New York University School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"25","key":"2019111811352876400_B1","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes.","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"2019111811352876400_B2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.848","article-title":"The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.","volume":"66","author":"Stein","year":"1985","journal-title":"Blood"},{"issue":"5","key":"2019111811352876400_B3","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"issue":"4","key":"2019111811352876400_B4","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2005-03-1306","article-title":"T-cell non-Hodgkin lymphoma.","volume":"107","author":"Rizvi","year":"2006","journal-title":"Blood"},{"issue":"12","key":"2019111811352876400_B5","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"issue":"5151","key":"2019111811352876400_B6","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.","volume":"263","author":"Morris","year":"1994","journal-title":"Science"},{"issue":"6","key":"2019111811352876400_B7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nm1769","article-title":"The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination.","volume":"14","author":"Chiarle","year":"2008","journal-title":"Nat Med"},{"issue":"4","key":"2019111811352876400_B8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/hon.897","article-title":"Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma?","volume":"27","author":"Fornari","year":"2009","journal-title":"Hematol Oncol"},{"issue":"10","key":"2019111811352876400_B9","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1182\/blood-2004-03-1037","article-title":"Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling.","volume":"104","author":"Bonzheim","year":"2004","journal-title":"Blood"},{"issue":"2","key":"2019111811352876400_B10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3121\/cmr.2010.891","article-title":"PAX-5: a valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms.","volume":"8","author":"Desouki","year":"2010","journal-title":"Clin Med Res"},{"issue":"3","key":"2019111811352876400_B11","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2019111811352876400_B12","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/modpathol.2010.225","article-title":"Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.","volume":"24","author":"Wada","year":"2011","journal-title":"Mod Pathol"},{"issue":"21","key":"2019111811352876400_B13","first-page":"322","article-title":"Prognostic factors and long term outcome of 138 adults with systemic anaplastic large-cell lymphoma: a retrospective study by the Groupe d'Etude Des Lymphomes De l'Adulte (GELA) [abstract].","volume":"116","author":"Sibon","year":"2010","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"issue":"5","key":"2019111811352876400_B14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.humpath.2005.03.004","article-title":"Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas.","volume":"36","author":"Thompson","year":"2005","journal-title":"Hum Pathol"},{"issue":"5","key":"2019111811352876400_B15","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/blood-2006-06-028969","article-title":"Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes.","volume":"109","author":"Lamant","year":"2007","journal-title":"Blood"},{"issue":"3","key":"2019111811352876400_B16","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI26833","article-title":"Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets.","volume":"117","author":"Piccaluga","year":"2007","journal-title":"J Clin Invest"},{"issue":"11","key":"2019111811352876400_B17","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1038\/leu.2009.161","article-title":"Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.","volume":"23","author":"Eckerle","year":"2009","journal-title":"Leukemia"},{"issue":"5","key":"2019111811352876400_B18","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","article-title":"Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.","volume":"115","author":"Iqbal","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2019111811352876400_B19","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2007.06924.x","article-title":"Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas.","volume":"140","author":"Salaverria","year":"2008","journal-title":"Br J Haematol"},{"issue":"9","key":"2019111811352876400_B20","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2008.20.9759","article-title":"Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms.","volume":"28","author":"Piva","year":"2010","journal-title":"J Clin Oncol"},{"issue":"29","key":"2019111811352876400_B21","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1200\/JCO.2005.01.3870","article-title":"Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations.","volume":"23","author":"Agnelli","year":"2005","journal-title":"J Clin Oncol"},{"issue":"37","key":"2019111811352876400_B22","doi-asserted-by":"crossref","first-page":"16228","DOI":"10.1073\/pnas.1009719107","article-title":"Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma.","volume":"107","author":"Merkel","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2019111811352876400_B23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/08830180903093796","article-title":"miR-155: on the crosstalk between inflammation and cancer.","volume":"28","author":"Tili","year":"2009","journal-title":"Int Rev Immunol"},{"issue":"19","key":"2019111811352876400_B24","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"issue":"25","key":"2019111811352876400_B25","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1182\/blood-2010-05-231548","article-title":"Peripheral T-cell lymphoma.","volume":"117","author":"Foss","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2019111811352876400_B26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1046\/j.1365-2559.2003.01726.x","article-title":"ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified.","volume":"43","author":"ten Berge","year":"2003","journal-title":"Histopathology"},{"issue":"6","key":"2019111811352876400_B27","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1080\/10428190701342000","article-title":"Hodgkin-like anaplastic large cell lymphoma (previously designated in the REAL classification) has same immunophenotypic features to classical Hodgkin lymphoma.","volume":"48","author":"Tamaru","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"2019111811352876400_B28","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"issue":"3","key":"2019111811352876400_B29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2141.2009.07956.x","article-title":"High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus.","volume":"148","author":"Hartmann","year":"2010","journal-title":"Br J Haematol"},{"issue":"15","key":"2019111811352876400_B30","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1158\/1078-0432.CCR-04-0269","article-title":"Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes.","volume":"10","author":"Martinez-Delgado","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"22","key":"2019111811352876400_B31","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","article-title":"Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation.","volume":"67","author":"Piccaluga","year":"2007","journal-title":"Cancer Res"},{"issue":"6","key":"2019111811352876400_B32","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1470-2045(05)70213-8","article-title":"Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specified.","volume":"6","author":"Piccaluga","year":"2005","journal-title":"Lancet Oncol"},{"issue":"6060","key":"2019111811352876400_B33","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.1216427","article-title":"Medicine. Personalized cancer diagnostics.","volume":"334","author":"Corless","year":"2011","journal-title":"Science"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/6\/1274\/1362555\/zh803212001274.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/6\/1274\/1362555\/zh803212001274.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T16:44:23Z","timestamp":1574095463000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/6\/1274\/30521\/Identification-of-a-3gene-model-as-a-powerful"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,9]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,8,9]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-01-405555","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,9]]}}}